407 related articles for article (PubMed ID: 37447164)
21. Effects of a carbohydrate-restricted diet on hepatic lipid content in adolescents with non-alcoholic fatty liver disease: A pilot, randomized trial.
Goss AM; Dowla S; Pendergrass M; Ashraf A; Bolding M; Morrison S; Amerson A; Soleymani T; Gower B
Pediatr Obes; 2020 Jul; 15(7):e12630. PubMed ID: 32128995
[TBL] [Abstract][Full Text] [Related]
22. Tcf7l2 in hepatocytes regulates de novo lipogenesis in diet-induced non-alcoholic fatty liver disease in mice.
Lee DS; An TH; Kim H; Jung E; Kim G; Oh SY; Kim JS; Chun HJ; Jung J; Lee EW; Han BS; Han DH; Lee YH; Han TS; Hur K; Lee CH; Kim DS; Kim WK; Park JW; Koo SH; Seong JK; Lee SC; Kim H; Bae KH; Oh KJ
Diabetologia; 2023 May; 66(5):931-954. PubMed ID: 36759348
[TBL] [Abstract][Full Text] [Related]
23. Non-alcoholic fatty liver disease severity and metabolic complications in obese children: impact of omega-3 fatty acids.
Spahis S; Alvarez F; Ahmed N; Dubois J; Jalbout R; Paganelli M; Grzywacz K; Delvin E; Peretti N; Levy E
J Nutr Biochem; 2018 Aug; 58():28-36. PubMed ID: 29864682
[TBL] [Abstract][Full Text] [Related]
24. Lifestyle predictors of obese and non-obese patients with nonalcoholic fatty liver disease: A cross-sectional study.
Kwak JH; Jun DW; Lee SM; Cho YK; Lee KN; Lee HL; Lee OY; Choi HS; Yoon BC
Clin Nutr; 2018 Oct; 37(5):1550-1557. PubMed ID: 28918170
[TBL] [Abstract][Full Text] [Related]
25. Berberine improves glucogenesis and lipid metabolism in nonalcoholic fatty liver disease.
Zhao L; Cang Z; Sun H; Nie X; Wang N; Lu Y
BMC Endocr Disord; 2017 Feb; 17(1):13. PubMed ID: 28241817
[TBL] [Abstract][Full Text] [Related]
26. Overview of Non-Alcoholic Fatty Liver Disease (NAFLD) and the Role of Sugary Food Consumption and Other Dietary Components in Its Development.
Vancells Lujan P; Viñas Esmel E; Sacanella Meseguer E
Nutrients; 2021 Apr; 13(5):. PubMed ID: 33923255
[TBL] [Abstract][Full Text] [Related]
27. Fructose intake is not associated to the risk of hepatic fibrosis in patients with Non-Alcoholic Fatty Liver Disease (NAFLD).
Azevedo VZ; Dall'Alba V
Clin Nutr; 2021 Jun; 40(6):4275-4283. PubMed ID: 33551215
[TBL] [Abstract][Full Text] [Related]
28. The impact of health status, diet and lifestyle on non-alcoholic fatty liver disease: Narrative review.
Alalwani J; Eljazzar S; Basil M; Tayyem R
Clin Obes; 2022 Aug; 12(4):e12525. PubMed ID: 35412016
[TBL] [Abstract][Full Text] [Related]
29. Validation of water-fat MRI and proton MRS in assessment of hepatic fat and the heterogeneous distribution of hepatic fat and iron in subjects with non-alcoholic fatty liver disease.
Hui SCN; So HK; Chan DFY; Wong SKH; Yeung DKW; Ng EKW; Chu WCW
Eur J Radiol; 2018 Oct; 107():7-13. PubMed ID: 30292275
[TBL] [Abstract][Full Text] [Related]
30. What are the main areas of focus to prevent or treat non-alcoholic fatty liver disease?
Mansour A; Hekmatdoost A; Mirmiran P
J Dig Dis; 2019 Jun; 20(6):271-277. PubMed ID: 30968561
[TBL] [Abstract][Full Text] [Related]
31. Low physical activity and energy dense Malaysian foods are associated with non-alcoholic fatty liver disease in centrally obese but not in non-centrally obese patients with diabetes mellitus.
Chan WK; Tan AT; Vethakkan SR; Tah PC; Vijayananthan A; Goh KL
Asia Pac J Clin Nutr; 2015; 24(2):289-98. PubMed ID: 26078246
[TBL] [Abstract][Full Text] [Related]
32. Effects of lifestyle interventions on clinical characteristics of patients with non-alcoholic fatty liver disease: A meta-analysis.
Katsagoni CN; Georgoulis M; Papatheodoridis GV; Panagiotakos DB; Kontogianni MD
Metabolism; 2017 Mar; 68():119-132. PubMed ID: 28183444
[TBL] [Abstract][Full Text] [Related]
33. The role of nutrition in non-alcoholic fatty liver disease treatment in obese children.
Guimber D; Debray D; Bocquet A; Briend A; Chouraqui JP; Darmaun D; Feillet F; Frelut ML; Hankard R; Lapillonne A; Peretti N; Rozé JC; Simeoni U; Turck D; Dupont C; Comité de Nutrition de la Société Française de Pédiatrie Cnsfp
Arch Pediatr; 2022 Jan; 29(1):1-11. PubMed ID: 34758930
[TBL] [Abstract][Full Text] [Related]
34. New Insights into the Pathogenesis of Non-Alcoholic Fatty Liver Disease: Gut-Derived Lipopolysaccharides and Oxidative Stress.
Ferro D; Baratta F; Pastori D; Cocomello N; Colantoni A; Angelico F; Del Ben M
Nutrients; 2020 Sep; 12(9):. PubMed ID: 32927776
[TBL] [Abstract][Full Text] [Related]
35. Partial MCT1 invalidation protects against diet-induced non-alcoholic fatty liver disease and the associated brain dysfunction.
Hadjihambi A; Konstantinou C; Klohs J; Monsorno K; Le Guennec A; Donnelly C; Cox IJ; Kusumbe A; Hosford PS; Soffientini U; Lecca S; Mameli M; Jalan R; Paolicelli RC; Pellerin L
J Hepatol; 2023 Jan; 78(1):180-190. PubMed ID: 35995127
[TBL] [Abstract][Full Text] [Related]
36. Early biochemical observations point to nutritional strategies to manage non-alcoholic fatty liver disease.
Calder PC
Clin Sci (Lond); 2022 Jul; 136(13):1019-1023. PubMed ID: 35775425
[TBL] [Abstract][Full Text] [Related]
37. Diet-Induced Models of Non-Alcoholic Fatty Liver Disease: Food for Thought on Sugar, Fat, and Cholesterol.
Eng JM; Estall JL
Cells; 2021 Jul; 10(7):. PubMed ID: 34359974
[TBL] [Abstract][Full Text] [Related]
38. Role of diet and nutritional management in non-alcoholic fatty liver disease.
Fan JG; Cao HX
J Gastroenterol Hepatol; 2013 Dec; 28 Suppl 4():81-7. PubMed ID: 24251710
[TBL] [Abstract][Full Text] [Related]
39. Influence of the nutritional status and oxidative stress in the desaturation and elongation of n-3 and n-6 polyunsaturated fatty acids: Impact on non-alcoholic fatty liver disease.
Videla LA; Hernandez-Rodas MC; Metherel AH; Valenzuela R
Prostaglandins Leukot Essent Fatty Acids; 2022 Jun; 181():102441. PubMed ID: 35537354
[TBL] [Abstract][Full Text] [Related]
40. A review of non-alcoholic fatty liver disease in non-obese and lean individuals.
Ahadi M; Molooghi K; Masoudifar N; Namdar AB; Vossoughinia H; Farzanehfar M
J Gastroenterol Hepatol; 2021 Jun; 36(6):1497-1507. PubMed ID: 33217052
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
